OTTAWA, ON / ACCESSWIRE / May 15, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX-V:TBP) (OTCQB:TBPMF), a leader in cannabinoid-derived drug discovery and development and ARTOFIX a Quebec City based high performance mask manufacturer are pleased to announce that Tetra has secured a Medical Device Establishment License (MDEL) for a Class 1 medical device manufacturer for Artofix. This will allow Artofix to expedite the launch of a mask with the same minimum filtration efficiencyof 95% as the N-95 masks, and will meet the safety needs of healthcare professionals and other essential workers.
The ARTOFIX Healthcare Mask conforms to the high standards required for medical use, and were tested in healthcare institutions. Like N-95 masks, they will be adjustable and comfortable, both features that are essential for healthcare professionals.
Dr. Guy Chamberland, CEO & CRO Tetra Bio-Pharma commented, "As we stated in our April 8th news release, COVID-19 is unprecedented in our lifetime and calls for an unprecedented response from all of us. Tetra reached out to Jason Duval of Artofix to offer our services on a pro bono basis to help them set up the quality system required to be a manufacturer of a Class 1 medical device. Our team also assisted Artofix with the preparation of the MDEL application and submitted it on their behalf. Yesterday we were excited to learn that Health Canada approved the MDEL allowing Artofix to manufacture and distribute the first 100% Quebec-made N95-type mask. In this serious fight against this life-threatening virus, Tetra is proud to have been able to help Artofix bring this desperately needed protective equipment to our front-line healthcare workers. All Canadians should be proud and congratulate Artofix for stepping up to the plate!"
"The collaboration with Tetra really helped us out to accelerate the launch of the Artofix mask and I can't wait to see our mask on the faces of our dedicated healthcare workers. My thank you of the day, as Premier Mr Legault would say, goes to Tetra," commented Jason Duval Artofix General Manager.
About Tetra Bio-Pharma